-
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes MellitusK Ejiri, T Miyoshi, MUSCAT‐HF Study Investigators. -
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REALCavender MA, Norhammar A, CVD-REAL Investigators and Study Group.
-
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocolHeatley G, Sood P, MOMENTUM 3 Investigators.
-
Titration of Medical Therapy for Heart Failure With Reduced Ejection FractionSJ Greene, GC Fonarow, AD DeVore et al.
-
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart FailureCK Nagaraju, EL Robinson, KR Sipido et al.
-
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart AssociationKonstam MA, Kiernan MS, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia.
-
Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and ManagementA Pandey, D Kitzman, G Reeves.
-
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk FactorsSatoru Suzuki , K Kaikita, E Yamamoto et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
